Ibandronate sodium
Drug ingredientCAS 138844-81-2
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
13 FDA-registered drug labelers
A-S Medication Solutions
Apotex Corp
Apotex Inc.
Aurobindo Pharma Limited
Bionpharma Inc.
Dr. Reddy's Laboratories Limited
Emcure Pharmaceuticals Limited
Eugia US LLC
Golden State Medical Supply, Inc.
Macleods Pharmaceuticals Limited
Mylan Institutional LLC
Natco Pharma Limited
Sun Pharmaceutical Industries, Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Ibandronate Sodium
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS138844-81-2
PubChem CID23663991
DTXSIDDTXSID8046618
FormulaC9H24NNaO8P2
Mol. Weight359.23 g/mol
SMILESCCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].O.[Na+]
Data Sources
- PubChem · compound 23663991Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
Ibandronate sodium (CAS 138844-81-2) https://chemicalindependence.com/chemical/138844-81-2/ PubChem: 23663991. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/23663991 FDA National Drug Code directory: CAS 138844-81-2. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/